[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@JamesEKrause](/creator/twitter/JamesEKrause)
"@playerTwoQ @seedy19tron Taking profits from $MDGL And with some other multibagger biotechs bought in the april to june 2025 time frame"  
[X Link](https://x.com/JamesEKrause/status/1971545285429178601) [@JamesEKrause](/creator/x/JamesEKrause) 2025-09-26T12:00Z 13.2K followers, 1258 engagements


"@SnupSnus $MDGL $AXSM and $OCUL. But I must point out that $CRVS is rapidly approaching the 'Four Horsemen'. Please do and share your own due diligence"  
[X Link](https://x.com/JamesEKrause/status/1971613245883715667) [@JamesEKrause](/creator/x/JamesEKrause) 2025-09-26T16:30Z 13.2K followers, XXX engagements


"On the topic of 'why is Madrigal Pharmaceuticals $MDGL currently undervalued Current MDGL mkt cap $9.6B"  
[X Link](https://x.com/JamesEKrause/status/1977088199026786534) [@JamesEKrause](/creator/x/JamesEKrause) 2025-10-11T19:05Z 13.2K followers, 5906 engagements


"Regarding the accurate spelling of Aclaris $ACLS. Disclosure: I picked up some share ystdy for the 2026 ews flow. Never really followed the company before as they are friends with the 'bad luck bears'. Their approaches today are reasonable but 2026 is do or die. Activist investors such as Kevin T may have helped buoy the ship but it is all about the next yr company trial readouts. For the #ITK inhibitor with more acute selectivity (IND in 2026) this may be too little too late if the clintrials do not pan out. I invested since I like the risk reward but I sure would like to know the FDA regs"  
[X Link](https://x.com/JamesEKrause/status/1978577493327331655) [@JamesEKrause](/creator/x/JamesEKrause) 2025-10-15T21:43Z 13.2K followers, 1348 engagements


"$AXSM Axsome Therapeutics Highlights Data Across Its Leading Neuroscience Pipeline at Psych Congress 2025 Major Depressive Disorder Title: Initiating Auvelity (dextromethorphan XX mg-bupropion XXX mg) in Patients with Major Depressive Disorder: Expert Panel Consensus Recommendations Presentation Date and Time: Friday September XX 1:30 - 3:00 p.m. and 6:00 - 7:15 p.m.; Saturday September XX 1:30 - 3:00 p.m. PT Lead Author:Anita H. Clayton MD Professor and Chair of Psychiatry and Neurobehavioral Sciences at the University of Virginia School of Medicine Poster Number: XXX Alzheimers Disease"  
[X Link](https://x.com/JamesEKrause/status/1968283331381940576) [@JamesEKrause](/creator/x/JamesEKrause) 2025-09-17T11:58Z 13.2K followers, 2971 engagements


"A $CRVS ITK degrader program would definitely be of interest. I would assume significant ongoing competition"  
[X Link](https://x.com/JamesEKrause/status/1970833458353304044) [@JamesEKrause](/creator/x/JamesEKrause) 2025-09-24T12:51Z 13.2K followers, 4286 engagements


"$IMRX Company PR on pancreatic patient data update with Tebimetinib + MGNP note on stock offering and a Reuters News Brief. Sept XX (Reuters) 5:21 PM ET Immuneering Corp * IMMUNEERING ANNOUNCES EXTRAORDINARY XX% OVERALL SURVIVAL AT X MONTHS IN FIRST-LINE PANCREATIC CANCER PATIENTS TREATED WITH ATEBIMETINIB + MGNP * IMMUNEERING CORP(IMRX) - ATEBIMETINIB + MGNP SHOWS XX% PFS AT X MONTHS IN PANCREATIC CANCER * IMMUNEERING CORP(IMRX) - EXPECTS REGULATORY FEEDBACK ON PIVOTAL TRIAL PLANS IN Q4 2025 * IMMUNEERING CORP(IMRX) - TO INITIATE PIVOTAL TRIAL BY END OF 2025"  
[X Link](https://x.com/JamesEKrause/status/1971000627325988965) [@JamesEKrause](/creator/x/JamesEKrause) 2025-09-24T23:55Z 13.2K followers, 6954 engagements


"On the heterogeneity of Metabolic Dysfunction-Associated Steatotic Liver Disease"  
[X Link](https://x.com/JamesEKrause/status/1976646954235875617) [@JamesEKrause](/creator/x/JamesEKrause) 2025-10-10T13:52Z 13.2K followers, 2374 engagements


"Performing some DD on $IDYA IDEAYA Biosciences trying to get a synopsis of their many biopharma collaborations. New to this name fwiw. Some friends of mine on X believe this company may be a buyout candidate. Current mkt cap $2.3B with some uncertainty of # of fully diluted shares (stock option grants etc). As usual please feel free to provide commentary (+ and -) on this interesting company/business plan. Partnered Programs and Collaborative Details via Grok my consultant. IDEAYA Biosciences has established multiple strategic partnerships to advance its precision oncology pipeline focusing"  
[X Link](https://x.com/JamesEKrause/status/1977085929811583266) [@JamesEKrause](/creator/x/JamesEKrause) 2025-10-11T18:56Z 13.2K followers, 16.7K engagements


"On the ITK enzyme and its inhibition for TH2 inflammatory diseases. I will be listening in on the Aclarus presentations today: Aclaris Therapeutics to Host In-Person and Webcast R&D Day Patient Focused Innovation: Addressing Gaps in Immuno-Inflammatory Markets in New York on October XX 2025 $ACRS $CRVS"  
[X Link](https://x.com/JamesEKrause/status/1978082130614698409) [@JamesEKrause](/creator/x/JamesEKrause) 2025-10-14T12:55Z 13.2K followers, 8733 engagements


"$CRVS is starting to get recognized"  
[X Link](https://x.com/JamesEKrause/status/1978536636733391182) [@JamesEKrause](/creator/x/JamesEKrause) 2025-10-15T19:01Z 13.2K followers, 10.1K engagements


"Madrigal's CEO Bill Seybold discusses the $MDGL $MASH market and sales on CNBC"  
[X Link](https://x.com/JamesEKrause/status/1978953279380787610) [@JamesEKrause](/creator/x/JamesEKrause) 2025-10-16T22:36Z 13.2K followers, 3839 engagements


"Grok for the purposes of continuing due diligence tell me about the business plan pipeline most valuable asset the management and investors in Ideaya Biosciences $IDYA"  
[X Link](https://x.com/JamesEKrause/status/1979549315434770694) [@JamesEKrause](/creator/x/JamesEKrause) 2025-10-18T14:05Z 13.2K followers, 1836 engagements